T. Rowe Price Associates
SKIN icon

T. Rowe Price Associates’s SkinHealth Systems SKIN Stock Holding History

T. Rowe Price Associates’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Sell
69,430
-62,434
-47% -$47.7K ﹤0.01% 3195
2026
Q1 		$118K Buy
131,864
+21,153
+19% +$26K ﹤0.01% 2962
2025
Q4 		$154K Hold
110,711
– – ﹤0.01% 2872
2025
Q3 		$221K Sell
110,711
-59,338
-35% -$120K ﹤0.01% 2754
2025
Q2 		$325K Buy
170,049
+25,252
+17% +$35.6K ﹤0.01% 2497
2025
Q1 		$195K Buy
144,797
+30,650
+27% +$46.7K ﹤0.01% 2653
2024
Q4 		$182K Buy
114,147
+18,400
+19% +$28.9K ﹤0.01% 2719
2024
Q3 		$138K Buy
95,747
+19,300
+25% +$31.6K ﹤0.01% 2764
2024
Q2 		$147K Buy
76,447
+1,166
+2% +$3.28K ﹤0.01% 2669
2024
Q1 		$335K Buy
75,281
+5,934
+9% +$19.3K ﹤0.01% 2387
2023
Q4 		$216K Buy
69,347
+19,150
+38% +$71.9K ﹤0.01% 2513
2023
Q3 		$303K Buy
50,197
+4,237
+9% +$29.8K ﹤0.01% 2331
2023
Q2 		$385K Buy
45,960
+1,389
+3% +$14.4K ﹤0.01% 2253
2023
Q1 		$563K Sell
44,571
-3,226
-7% -$37.3K ﹤0.01% 2057
2022
Q4 		$435K Buy
47,797
+362
+0.8% +$3.91K ﹤0.01% 2195
2022
Q3 		$560K Buy
47,435
+11,317
+31% +$143K ﹤0.01% 2067
2022
Q2 		$464K Buy
36,118
+12,702
+54% +$170K ﹤0.01% 2249
2022
Q1 		$395K Buy
23,416
+11,436
+95% +$189K ﹤0.01% 2442
2021
Q4 		$289K Buy
+11,980
New +$309K ﹤0.01% 2604

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

T. Rowe Price Associates's SKIN Position: Q2 2026 in Review

T. Rowe Price Associates reduced its SkinHealth Systems (SKIN) stake by 47% in Q2 2026, selling an estimated $47.7K and leaving 69,430 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

T. Rowe Price Associates first reported a position in SKIN in Q4 2021 and has held it in 19 quarters since. The position peaked at $563K in Q1 2023. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • T. Rowe Price Associates held 69,430 shares of SkinHealth Systems worth $49K as of Q2 2026.
  • T. Rowe Price Associates sold 62,434 SkinHealth Systems shares in Q2 2026, an estimated $47.7K.
  • SkinHealth Systems made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3195 holding.
  • T. Rowe Price Associates first reported a position in SkinHealth Systems in Q4 2021 and has held it in 19 quarters since.
  • T. Rowe Price Associates's SkinHealth Systems position peaked at $563K in Q1 2023.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.